US Patent 8039483 Quinuclidine carbonate salts and medicinal composition thereof
Patent 8039483 was granted and assigned to Chiesi Farmaceutici S.p.A. on October, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 14 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+193 characters)
Article
Patent abstract
Quinuclidine carbonate derivatives act as muscarinic receptor antagonists and are effective for the prevention and/or treatment of a broncho-obstructive or inflammatory diseases.
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Gabriele Amari0
Maurizio Delcanale0
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08039483 Quinuclidine carbonate salts and medicinal composition thereof US Patent 8039483 Quinuclidine carbonate salts and medicinal composition thereof
Infobox
Patent Number
080394830
Patent Number
80394830
Edits on 6 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080394830
Date of Patent
October 18, 2011
0Patent Application Number
125122620
Date Filed
July 30, 2009
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08039483 Quinuclidine carbonate salts and medicinal composition thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08039483
Date of patent
October 18, 2011
Patent application number
12512262
Date Filed
July 30, 2009
Patent primary examiner
Find more entities like US Patent 8039483 Quinuclidine carbonate salts and medicinal composition thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
